Extending neuropsychological assessments into the primary mental ability space

Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition
K W SchaieLinda Teri

Abstract

A battery of 17 neuropsychological tests (including the CERAD battery) and 17 psychometric ability tests were administered to a sample of 499 participants of the Seattle Longitudinal study who had been given the psychometric ability tests seven and 14 years earlier. The neuropsychological tests were projected into a 5-factor psychometric ability space by means of extension analysis. The concurrent regressions of the neuropsychology tests on the psychometric ability tests were then used to estimate neuropsychology test scores from the psychometric ability tests administered in 1984, 1991 and 1998. Neuropsychologists then rated the study participants as either normal, suspect or cognitively impaired in 1998. Changes in estimated test scores were computed over seven and fourteen years. Significant odds ratios between normal and cognitively impaired groups were found for all neuropsychological tests over the proximal period and for most tests over the 14-year period. Similar findings occurred for the odds ratios between the normal and suspect groups for the most proximal 7-year changes.

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Sep 1, 1992·Journal of the American Geriatrics Society·T N Tombaugh, N J McIntyre
Sep 1, 1991·Journal of the American Geriatrics Society·R F Uhlmann, E B Larson
Sep 1, 1991·Psychology and Aging·K W SchaieS L Willis
Mar 1, 1986·Psychology and Aging·P P VitalianoP N Prinz
Dec 1, 1986·Journal of Clinical and Experimental Neuropsychology·W G Van GorpR Henry
Oct 1, 1973·The British Journal of Psychiatry : the Journal of Mental Science·B Isaacs, A T Kennie
Aug 1, 1971·Scientific American·R C Atkinson, R M Shiffrin
May 1, 1984·Archives of Neurology·M StorandtC P Hughes
Jan 1, 1995·The Journal of Neuropsychiatry and Clinical Neurosciences·R C GreenJ Green
Mar 1, 1993·The American Journal of Emergency Medicine·F B Epstein
May 12, 1993·JAMA : the Journal of the American Medical Association·R M CrumM F Folstein
May 1, 1995·Journal of the International Neuropsychological Society : JINS·D A CahnE Barrett-Connor
Jun 1, 1994·Assessment·G E SmithR C Petersen
Apr 9, 1998·Psychology and Aging·K Warner SchaieRobert C Intrieri

❮ Previous
Next ❯

Methods Mentioned

BETA
PMA

Software Mentioned

Amos
FULD
ADEPT
Word

Related Feeds

Alzheimer's Disease: Early Markers

Alzheimer's disease (AD) is a neurodegenerative disease characterized by progressive cognitive and behavioral decline. Targeting markers in the earliest stages of the disease may mitigate the progression of AD. This feed focuses on early diagnosis and markers, as well as environmental, pharmacological, and drug-response biomarkers associated with this disease.